We are uploading a video of the briefing session for our data release at the SABCS (San Antonio Breast Cancer Society) 2020 which took place from December 8 to 11.

To help shareholders, bio investors, reporters and analysts understand the data and its meaning, we held an online briefing session on December 14.

We announced the latest interim results of phase Ib clinical trial of olinvacimab in combination with MSD’s pembrolizumab for metastatic triple-negative breast cancer at SABCS 2020.

Please check the link below for the video.

https://youtu.be/UHy32lpiHMM